Key result
Low-dose IL-2 expands regulatory T cells and suppresses inflammatory T cell polarization after ACS.
Why the study?
Does low-dose interleukin-2 induce clonal expansion of effector regulatory T cells in patients with acute coronary syndromes?
Does low-dose interleukin-2 induce clonal expansion of effector regulatory T cells in patients with acute coronary syndromes?
Answers are grounded in this paper and cite their sources.
Low-dose IL-2 promotes the clonal expansion of immunosuppressive effector Treg cells in ACS patients, offering a potential therapeutic mechanism for targeting inflammation in cardiovascular disease.
Targeting inflammation in atherosclerotic cardiovascular disease remains a major unmet need. Low-dose interleukin-2 (IL-2LD) selectively increases regulatory T (Treg) cell numbers in patients with coronary artery disease. Here we combine single-cell transcriptomics and T cell receptor analyses and show that IL-2LD clonally expands effector Treg cells in patients with acute coronary syndromes. The clonally expanded Treg cells upregulate key immunosuppressive and metabolic pathways and show an increased number of predicted ligand-receptor interactions. These Treg cells also display similar predicted antigen specificities, which cluster with published sequences specific to atherosclerotic cardiovascular disease. By tracking the T cell receptors of single cells over time, we identify an inflammatory polarization of the T cell compartment after myocardial infarction, which is restrained by IL-2LD. We identify BACH2 as a repressor of the Treg effector program. However, BACH2-mediated regulation is bypassed with IL-2LD. Overall, these results lend insight into the IL-2-driven clonal expansion program in human Treg cells, with important therapeutic implications for patients with cardiovascular and other immune-mediated diseases.
No takes yet. Share an insight, caveat, or question.
Case et al. (2025) studied Acute coronary syndromes. Low-dose interleukin-2 (IL-2LD) was evaluated on Clonal expansion of effector Treg cells and inflammatory polarization. Low-dose interleukin-2 clonally expands effector regulatory T cells and restrains inflammatory polarization of the T cell compartment following acute coronary syndromes.
Synapse has enriched 10 related papers. Consider them for comparative context: